Hyaluronidase is an enzyme used to break down hyaluronic acid filler. It can be essential in urgent vascular complications and useful for selected aesthetic problems, but it is not a perfect “undo button.” Response varies with product, cross-linking, location, amount, tissue changes and treatment technique.
What hyaluronidase can and cannot treat
| Situation | Possible role | Important limitation |
|---|---|---|
| Hyaluronic acid filler | May reduce or dissolve the product | More than one session may be needed |
| Suspected vascular compromise | Part of urgent medical management | Requires immediate expert assessment—not routine scheduling |
| Malar edema after filler | May help if hyaluronic acid contributes | Edema can have several causes and may persist |
| Biostimulator, PMMA, silicone or fat | No direct dissolving effect | These materials require different evaluation |
| Fibrosis or stretched tissue | Does not directly reverse structural change | Removing filler may not restore the previous anatomy |
Why results are variable
Hyaluronidase cleaves hyaluronic acid chains, reducing the gel’s structure and water-binding behavior. The breakdown products are then handled by the tissues. A dense or highly cross-linked filler, a large deposit or dispersed material may require staged treatment. Ultrasound can help locate material and guide injections when the anatomy or history is uncertain.
It is inaccurate to say that hyaluronic acid filler can always be completely and instantly reversed. It is also inaccurate to say that hyaluronidase merely liquefies filler without degradation. The clinical reality depends on the product and tissue response.
Under-eye filler and malar edema
The lower eyelid and malar region have delicate lymphatic and anatomical relationships. Filler can persist, migrate or retain water, but festoons and malar edema may also exist without filler. Dissolving visible product may improve one contributor while leaving laxity, pigmentation, vascular show or fluid-related swelling unchanged.
Risks of treatment
Bruising, swelling, discomfort, asymmetry, incomplete correction and temporary loss of desired volume may occur. Allergic reactions are uncommon but possible. Urgent treatment of a vascular event follows a different risk–benefit calculation from elective aesthetic dissolution.
Planning facial surgery after fillers
Before blepharoplasty, midface surgery or facelift, patients should disclose products, dates and locations. Dermatologic ultrasound may be recommended. Surgery should not be scheduled on the assumption that one hyaluronidase session will normalize every tissue plane.
Belvivere provides hospital-based care and international coordination. Read more about injectables before facial surgery and malar edema and festoons.
